These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 24295642)

  • 21. Pharmacokinetic analysis of enterohepatic circulation of 4-[2-(4-isopropylbenzamido)ethoxy]benzoic acid. Effect of intramolecular rearrangement of its acyl glucuronide.
    Komura H; Fukui H; Sasaki H; Morino A
    Drug Metab Dispos; 1992; 20(4):585-91. PubMed ID: 1356739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A pharmacokinetic model for analysis of drug disposition profiles undergoing enterohepatic circulation.
    Wajima T; Yano Y; Oguma T
    J Pharm Pharmacol; 2002 Jul; 54(7):929-34. PubMed ID: 12162711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered disposition of drugs in acute renal failure rat models: drug development strategies and perspectives.
    Srinivas NR
    Arzneimittelforschung; 2010; 60(12):731-48. PubMed ID: 21265465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intestinal absorption and biliary excretion kinetics of 14C-labeled methadone in the rat.
    Turnbow JM; Thaete LG; Peters MA
    Arch Int Pharmacodyn Ther; 1976 Jun; 221(2):311-22. PubMed ID: 962439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Population pharmacokinetic modeling for enterohepatic recirculation in Rhesus monkey.
    Shou M; Lu W; Kari PH; Xiang C; Liang Y; Lu P; Cui D; Emary WB; Michel KB; Adelsberger JK; Brunner JE; Rodrigues AD
    Eur J Pharm Sci; 2005 Oct; 26(2):151-61. PubMed ID: 16085400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of flunixin in the cat: enterohepatic circulation and active transport mechanism in the liver.
    Horii Y; Ikenaga M; Shimoda M; Kokue E
    J Vet Pharmacol Ther; 2004 Apr; 27(2):65-9. PubMed ID: 15096102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mean residence time for drugs subject to enterohepatic cycling.
    Shepard TA; Lockwood GF; Aarons LJ; Abrahams ID
    J Pharmacokinet Biopharm; 1989 Jun; 17(3):327-45. PubMed ID: 2810071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An experimental design strategy for quantitating complex pharmacokinetic models: enterohepatic circulation with time-varying gallbladder emptying as an example.
    Wang YM; Reuning RH
    Pharm Res; 1992 Feb; 9(2):169-77. PubMed ID: 1553336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of enterohepatic circulation on the pharmacokinetics of diflunisal in rats.
    Lin JH; Yeh KC; Duggan DE
    Drug Metab Dispos; 1985; 13(3):321-6. PubMed ID: 2861991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enterohepatic circulation of organochlorine compounds: a site for nutritional intervention.
    Jandacek RJ; Tso P
    J Nutr Biochem; 2007 Mar; 18(3):163-7. PubMed ID: 17296488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A perspective on the prediction of drug pharmacokinetics and disposition in drug research and development.
    Di L; Feng B; Goosen TC; Lai Y; Steyn SJ; Varma MV; Obach RS
    Drug Metab Dispos; 2013 Dec; 41(12):1975-93. PubMed ID: 24065860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo disposition and metabolism of madecassoside, a major bioactive constituent in Centella asiatica (L.) Urb.
    Leng DD; Han WJ; Rui Y; Dai Y; Xia YF
    J Ethnopharmacol; 2013 Nov; 150(2):601-8. PubMed ID: 24091240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of intravenous luxabendazole in rabbits: influence of the enterohepatic circulation.
    Alvarez-Bujidos L; Ortiz AI; Molina-Martínez IT; Cubría C; Ordóñez D
    Biopharm Drug Dispos; 1998 Jul; 19(5):341-7. PubMed ID: 9673786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on the pharmacokinetics and the metabolism of gitoxin in the guinea-pig: II. the enteral absorption and the enterohepatic recirculation.
    Kadima LN; Lesne M
    Arch Int Pharmacodyn Ther; 1982 Jul; 258(1):4-14. PubMed ID: 7138145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Doxorubicin and daunorubicin plasmatic, hepatic and renal disposition in the rabbit with or without enterohepatic circulation.
    Maniez-Devos DM; Baurain R; Lesne M; Trouet A
    J Pharmacol; 1986; 17(1):1-13. PubMed ID: 3713196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of the progestin dienogest (STS 557) in rabbits.
    Hillesheim HG; Ritter P; Valentin U; Hobe G
    Exp Clin Endocrinol; 1989 Sep; 94(1-2):194-202. PubMed ID: 2599018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Role of the enterohepatic circulation of endogenous lipids in food lipid absorption].
    Gal'perin IuM; Alimova EK; Astvatsatur'ian AT; Mikhas' NK; Baklykova NM
    Fiziol Zh SSSR Im I M Sechenova; 1982 Jan; 68(1):100-6. PubMed ID: 7060796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Commentary: theoretical predictions of flow effects on intestinal and systemic availability in physiologically based pharmacokinetic intestine models: the traditional model, segregated flow model, and QGut model.
    Pang KS; Chow EC
    Drug Metab Dispos; 2012 Oct; 40(10):1869-77. PubMed ID: 22745334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro and in vivo approaches to characterize transporter-mediated disposition in drug discovery.
    Feng B; Varma MV; Costales C; Zhang H; Tremaine L
    Expert Opin Drug Discov; 2014 Aug; 9(8):873-90. PubMed ID: 24857286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regional intestinal drug permeation: biopharmaceutics and drug development.
    Lennernäs H
    Eur J Pharm Sci; 2014 Jun; 57():333-41. PubMed ID: 23988845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.